Jeremie Vitte

8PUBLICATIONS
30CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesSensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1).

|Apr 03, 2026
Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, revealing distinct impacts of targeted therapies.

Emily A Wright, Jeremie Vitte, Sara I Veiga

|Sep 28, 2024
Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells.

Brian Na, Blake Haist, Shilp R Shah

|Feb 19, 2024
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.

Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi

|Nov 08, 2023
Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials.

Verena Staedtke, Kara Anstett, David Bedwell

|Mar 22, 2023
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.

Christine Chiasson-MacKenzie, Jeremie Vitte, Ching-Hui Liu

Pageof 2

Frequent Collaborators

6 joint publications

Marco Giovannini

2 joint publications

Christine Chiasson-MacKenzie

2 joint publications

Andrea I McClatchey

1 joint publications

Giovanni Coppola